mls-101
mineralys therapeutics
['cardio']
at #acc23 #wccardio and want to learn about our work in #hypertension? join us at 3:15pm et as we present ph2 results on lorundrostat, our highly selective aldosterone synthase inhibitor. learn about targeting the underlying cause of hypertension: 
We're a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for hypertension.